UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An economic evaluation of the Enhanced Recovery After Surgery (ERAS) multisite implementation program for colorectal surgery in Alberta

Canadian Journal of Surgery, 2016-12, Vol.59 (6), p.415-421

2016

Volltextzugriff (PDF)

Cancer Screening Among the Overweight and Obese in Canada

American journal of preventive medicine, 2008-08, Vol.35 (2), p.127-132

2008

Volltextzugriff (PDF)

Post-Policy Implementation Review of Rapid Fetal Fibronectin (fFN) Testing for Preterm Labour in Alberta

Journal of obstetrics and gynaecology Canada, 2016-07, Vol.38 (7), p.659-666.e6

2016

Volltextzugriff (PDF)

Health Technology Optimization Analysis: Conceptual Approach and Illustrative Application

MDM policy & practice, 2018-01, Vol.3 (1), p.2381468318774804-2381468318774804

2018

Volltextzugriff (PDF)

The Economic Impact of Weight Regain

Gastroenterology research and practice, 2013-01, Vol.2013 (2013), p.1-10

2013

Volltextzugriff (PDF)

Does performance-based remuneration for individual health care practitioners affect patient care?: a systematic review

Annals of internal medicine, 2012-12, Vol.157 (12), p.889

2012

Volltextzugriff (PDF)

Blood pressure kiosks for medication therapy management programs: Business opportunity for pharmacists

Journal of the American Pharmacists Association, 2012-03, Vol.52 (2), p.188-194

2012

Volltextzugriff (PDF)

Increased Virtual Visits to Physicians During the COVID-19 Pandemic and Estimated Impact on Physician Compensation: The Case of Lung and Colorectal Cancers, Chronic Obstructive Pulmonary Diseases, and Heart Failure in Alberta, Canada

Telemedicine journal and e-health, 2024-07, Vol.30 (7), p.e2024-e2039

2024

Volltextzugriff (PDF)

Pharmacoeconomic evaluation of 10- and 13-valent pneumococcal conjugate vaccines

Vaccine, 2010-07, Vol.28 (33), p.5485-5490

2010

Volltextzugriff (PDF)

Cost-effectiveness and budget impact of adjunctive hyperbaric oxygen therapy for diabetic foot ulcers

International journal of technology assessment in health care, 2008-04, Vol.24 (2), p.178-183

2008

Volltextzugriff (PDF)

Effect of a Pharmacist-Managed Hypertension Program on Health System Costs: An Evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN)

Pharmacotherapy, 2012-06, Vol.32 (6), p.527-537

2012

Volltextzugriff (PDF)

Medical tourism and bariatric surgery: who pays?

Surgical endoscopy, 2014-12, Vol.28 (12), p.3329-3336

2014

Volltextzugriff (PDF)

Value Added by the Prevnar 13 Childhood Immunization Program in Alberta, Canada (2010–2015)

Drugs -- real world outcomes, 2015-09, Vol.2 (3), p.311-318

2015

Volltextzugriff (PDF)

Should vitamin B12 tablets be included in more Canadian drug formularies? An economic model of the cost-saving potential from increased utilisation of oral versus intramuscular vitamin B12 maintenance therapy for Alberta seniors

BMJ open, 2014-05, Vol.4 (5), p.e004501-e004501

2014

Volltextzugriff (PDF)

Should vitamin B 12 tablets be included in more Canadian drug formularies? An economic model of the cost-saving potential from increased utilisation of oral versus intramuscular vitamin B 12 maintenance therapy for Alberta seniors

BMJ open, 2014-05, Vol.4 (5), p.e004501

2014

Volltextzugriff (PDF)

BENEFITS OF PHARMACEUTICAL INNOVATION: THE CASE OF SIMVASTATIN IN CANADA

International journal of technology assessment in health care, 2012-10, Vol.28 (4), p.390-397

2012

Volltextzugriff (PDF)

Potential impacts of the Alberta fetal alcohol spectrum disorder service networks on secondary disabilities: a cost-benefit analysis

Journal of population therapeutics and clinical pharmacology, 2013, Vol.20 (2), p.e193-e200

2013

Volltextzugriff (PDF)

Prevnar 7 Childhood Immunization Program and Serotype Replacement: Changes in Pneumococcal Incidence and Resulting Impact on Health Care Costs in Alberta (2003–2008)

Drugs -- real world outcomes, 2015-06, Vol.2 (2), p.153-161

2015

Volltextzugriff (PDF)

Societal monetary benefits of pharmaceutical innovation: the case of ramipril in Canada

Journal of pharmaceutical health services research, 2013-12, Vol.4 (4), p.195-201

2013

Volltextzugriff (PDF)

An Economic Evaluation of the Parent–Child Assistance Program for Preventing Fetal Alcohol Spectrum Disorder in Alberta, Canada

Administration and policy in mental health and mental health services research, 2015-01, Vol.42 (1), p.10-18

2015

Volltextzugriff (PDF)

The Degree of Bedroom Personalization in Institutional and Homelike Settings for Persons with Dementia: A Quantitative Investigation

Canadian journal on aging, 2005-01, Vol.24 (4), p.329-337

2005

Volltextzugriff (PDF)

Post–Policy Implementation Review of Rapid Fetal Fibronectin (fFN) Testing for Preterm Labour in Alberta

Obstetrical & gynecological survey, 2016-12, Vol.71 (12), p.701-702

2016

Volltextzugriff (PDF)

Societal monetary benefits of pharmaceutical innovation: the case of ramipril in Canada: Benefits of pharmaceutical innovation

Journal of pharmaceutical health services research, 2013-12, Vol.4 (4), p.195-201

2013

Volltextzugriff (PDF)

The economics of chronic pain and the stated preference valuation of chronic pain disorders

Chuck, Anderson W

2008

Volltextzugriff (PDF)

Viewing Forced Climate Patterns Through an AI Lens

Geophysical research letters, 2019-11, Vol.46 (22), p.13389-13398

2019

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(32)

Publikationsform

Sprache

Englisch
(41)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(20)
Humans
(16)
Female
(9)
Aged
(8)
Alberta
(8)
Adult
(7)
Biological And Medical Sciences
(7)
Costs
(6)
Health Care Sciences & Services
(6)
Male
(6)
Middle Aged
(6)
Canada
(5)
Cost Control
(5)
Health Services
(5)
Medical Sciences
(5)
Public Health
(5)
Public, Environmental & Occupational Health
(5)
Cost-Benefit Analysis
(4)
General & Internal Medicine
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An economic evaluation of the Enhanced Recovery After Surgery (ERAS) multisite implementation program for colorectal surgery in Alberta

Cancer Screening Among the Overweight and Obese in Canada

Post-Policy Implementation Review of Rapid Fetal Fibronectin (fFN) Testing for Preterm Labour in Alberta

Health Technology Optimization Analysis: Conceptual Approach and Illustrative Application

The Economic Impact of Weight Regain

Does performance-based remuneration for individual health care practitioners affect patient care?: a systematic review

Blood pressure kiosks for medication therapy management programs: Business opportunity for pharmacists

Increased Virtual Visits to Physicians During the COVID-19 Pandemic and Estimated Impact on Physician Compensation: The Case of Lung and Colorectal Cancers, Chronic Obstructive Pulmonary Diseases, and Heart Failure in Alberta, Canada

Pharmacoeconomic evaluation of 10- and 13-valent pneumococcal conjugate vaccines

Cost-effectiveness and budget impact of adjunctive hyperbaric oxygen therapy for diabetic foot ulcers

Effect of a Pharmacist-Managed Hypertension Program on Health System Costs: An Evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN)

Medical tourism and bariatric surgery: who pays?

Value Added by the Prevnar 13 Childhood Immunization Program in Alberta, Canada (2010–2015)

Should vitamin B12 tablets be included in more Canadian drug formularies? An economic model of the cost-saving potential from increased utilisation of oral versus intramuscular vitamin B12 maintenance therapy for Alberta seniors

Should vitamin B 12 tablets be included in more Canadian drug formularies? An economic model of the cost-saving potential from increased utilisation of oral versus intramuscular vitamin B 12 maintenance therapy for Alberta seniors

BENEFITS OF PHARMACEUTICAL INNOVATION: THE CASE OF SIMVASTATIN IN CANADA

Potential impacts of the Alberta fetal alcohol spectrum disorder service networks on secondary disabilities: a cost-benefit analysis

Prevnar 7 Childhood Immunization Program and Serotype Replacement: Changes in Pneumococcal Incidence and Resulting Impact on Health Care Costs in Alberta (2003–2008)

Societal monetary benefits of pharmaceutical innovation: the case of ramipril in Canada

An Economic Evaluation of the Parent–Child Assistance Program for Preventing Fetal Alcohol Spectrum Disorder in Alberta, Canada

The Degree of Bedroom Personalization in Institutional and Homelike Settings for Persons with Dementia: A Quantitative Investigation

Post–Policy Implementation Review of Rapid Fetal Fibronectin (fFN) Testing for Preterm Labour in Alberta

Societal monetary benefits of pharmaceutical innovation: the case of ramipril in Canada: Benefits of pharmaceutical innovation

The economics of chronic pain and the stated preference valuation of chronic pain disorders

Viewing Forced Climate Patterns Through an AI Lens

Suchergebnisse filtern